Sensus Healthcare, Inc. $SRTS

What the company doesAI summary of filing

Sensus Healthcare, Inc. is a revenue-generating medical device company that develops and sells superficial radiation therapy (SRT) systems for treating non-melanoma skin cancer and keloid scars. The company manufactures three main SRT device models (SRT-100, SRT-100+, and SRT-100 Vision) through third-party manufacturers and sells them primarily to dermatology practices and radiation oncologists in the United States and internationally, with 955 units installed across 21 countries as of December 31, 2025. The company generates revenue through direct device sales, service contracts (Sentinel service program), a recurring revenue model called Fair Deal Agreement where it receives a percentage of reimbursement collections, financing programs, consumables, and operational healthcare services. The company also offers Sensus Link, a cloud-based software solution launched in February 2026. [10-K 2026-03-04]

Segments: SRT-100, SRT-100+, and SRT-100 Vision devices, Sentinel service program, Fair Deal Agreement, Consumables (lead shielding, radiation safety items, applicator tips)